NEWS
Johnson & Johnson halts rollout of vaccine in Europe amid US pause
Johnson & Johnson announced Tuesday that it is delaying the rollout of its COVID-19 vaccine in Europe amid concerns about potential blood clots in US recipients. “We are aware of an extremely rare disorder involving people with blood clots in combination with low platelets in a small number of individuals who have received our COVID-19…